Steven P. James Insider Profile
11 Followers
Steven P. James, Sr VP Commercial Ops at Exelixis, holds 0.00 shares in Exelixis (Ticker: EXEL), holds 0.00 shares in Allakos (Ticker: ALLK), holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC).
Steven P. James's Trading History
| ALLKAllakos | Sep 29, 2021 | ― | Uninformative Buy | 2.08K | $0.00 | |
| CASCCascadian Therapeutics | Mar 13, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| OCRXOcera Therapeutics | Dec 11, 2017 | ― | Uninformative Sell | 19.00K | $0.00 | |
| EXELExelixis | ― | Sr VP Commercial Ops | ― | $0.00 |
You May Also Like
Steven P. James insider profile FAQ
What is the percentage of profitable transactions made by Steven P. James?
The percentage of profitable transactions made by Steven P. James is 100%.
What is the average return per transaction made by Steven P. James?
The average return per transaction made by Steven P. James is 94.80%.
What stocks does Steven P. James hold?
Steven P. James holds: EXEL, CASC, ALLK, OCRX stocks.
What was Steven P. James's most profitable transaction?
Steven P. James’s most profitable transaction was an Informative Sell of ALLK stock on March 17, 2021. The return on the trade was 95.00%.
What is Steven P. James's role in Exelixis?
Steven P. James's role in Exelixis is Sr VP Commercial Ops.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
